EU Ends Approval for Buprofezin Insecticide Over Health Risk
18 November 2026, Brussels, BE: The European Commission has decided not to renew European Union approval for buprofezin, a widely used insect growth regulator insecticide, after the European Food Safety Authority concluded that the substance meets the criteria to be identified as an endocrine disruptor affecting the human thyroid.
Commission Implementing Regulation (EU) 2026/2517, adopted on November 12, 2026 and published in the Official Journal of the European Union on November 13, 2026, formally ends buprofezin’s approval under the EU’s pesticide framework, Regulation (EC) No 1107/2009. The decision removes buprofezin from the list of approved active substances in Annex Part A of Implementing Regulation (EU) No 540/2011, deleting the entry that had covered the chemical since its original EU approval under Directive 2011/6/EU.
Buprofezin is a chitin synthesis inhibitor used mainly against sucking pests such as whiteflies, planthoppers and scale insects on crops including citrus, cotton, rice and vegetables. Its EU approval had most recently been extended to March 15, 2027 under a separate measure, Implementing Regulation (EU) 2026/2348, adopted on October 23, 2026, but the non-renewal decision takes effect ahead of that extended date because it was taken before the extension expired.
EFSA’s Endocrine Disruption Finding
The non-renewal follows a peer review conducted by EFSA, which communicated its conclusion to the Commission on April 16, 2025, in an opinion published as EFSA Journal 2025;23(4):9392. EFSA found that buprofezin meets the criteria under Regulation (EC) No 1107/2009 to be identified as a thyroid-modality endocrine disruptor for humans, and that human exposure under realistic conditions of use could not be shown to be negligible. Under EU rules, an active substance identified as an endocrine disruptor can be approved only if exposure to it is negligible, so the finding alone was sufficient grounds for non-renewal under Article 20(1)(b) of the regulation.
EFSA also flagged data gaps that kept it from completing several parts of its assessment, including buprofezin’s endocrine-disrupting potential in non-mammalian organisms, consumer risk from residues in honey and in crops grown in rotation after treated fields, risk to bees and other non-target arthropods from use in non-permanent greenhouses, and risk to aquatic organisms.
Italy, the rapporteur member state for buprofezin, had submitted a draft renewal assessment report on September 9, 2021 that proposed renewing the approval based on the data available at the time. The Commission presented its own renewal report and a draft of the non-renewal regulation to the Standing Committee on Plants, Animals, Food and Feed on December 10, 2025, and the final regulation states that it is in line with the committee’s opinion. The applicant’s comments on the Commission’s findings were considered but did not resolve the underlying concerns about thyroid-related endocrine effects, according to the regulation’s text.
Compliance Deadlines for Member States
Under Article 3 of the new regulation, EU member states must withdraw any existing authorizations for plant protection products containing buprofezin no later than June 3, 2027. Member states may still grant growers and distributors a grace period to use up existing stocks under Article 46 of Regulation (EC) No 1107/2009, but any such grace period must expire no later than December 3, 2027, twelve months after the regulation enters into force.
The regulation enters into force twenty days after its Official Journal publication, which falls on December 3, 2026. From that date, buprofezin can no longer be placed on the market anywhere in the European Union as an active ingredient in new plant protection products, though products already authorized can remain on shelves and in use until the member state withdrawal deadline next year.
The non-renewal adds buprofezin to a line of insecticides removed from the EU market over endocrine-disruption concerns in recent years as part of the bloc’s ongoing review of older active substances under hazard-based approval criteria. Growers in citrus and rice-growing regions of southern and eastern Europe who have relied on buprofezin for resistance management in integrated pest programs will need to identify alternative products for scale insect and whitefly control ahead of the 2027 withdrawal deadline.
Also Read: Mahindra Launches 50 HP Compact Harvester Harvest Yuva for Small Farms
Global Agriculture is an independent international media platform covering agri-business, policy, technology, and sustainability. For editorial collaborations, thought leadership, and strategic communications, write to pr@global-agriculture.com







